oxonic acid has been researched along with Cancer of Paranasal Sinus in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasumatsu, R | 1 |
| Nakashima, T | 1 |
| Sato, M | 1 |
| Nakano, T | 1 |
| Kogo, R | 1 |
| Hashimoto, K | 1 |
| Sawatsubashi, M | 1 |
| Nakagawa, T | 1 |
| Okano, S | 1 |
| Tahara, M | 1 |
| Zenda, S | 1 |
| Fuse, N | 1 |
| Yoshino, T | 1 |
| Doi, T | 1 |
| Kawashima, M | 1 |
| Ogino, T | 1 |
| Hayashi, R | 1 |
| Ohtsu, A | 1 |
2 other studies available for oxonic acid and Cancer of Paranasal Sinus
| Article | Year |
|---|---|
Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemor | 2017 |
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug | 2012 |